Total raised
$1.4M
Last: Pre-Seed 2025-01
Stage
Pre-Seed
Founded
2019
Headcount
5
HQ
Tel Mond
Sector
Health Tech & Life Sciences
About
NimBio is the developer of a non-invasive Inflammometer™ - a technology that can be part of everyday devices like smartwatches or fitness bands. The company's solution is AI-powered, non-invasive technology, it can detect the early signs of inflammation in real time before a flare begins The Inflammometer™, is a groundbreaking non-invasive technology designed to passively collect real-time data for the early detection of flares in chronic inflammatory diseases to reduce hospitalizations and complications through timely treatment optimization.
Funding history · 3 rounds · $1.4M total
2025-01
Pre-Seed
$500K
2022-11
Undisclosed
$870K
2019-09
Seed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When was NimBio founded and what is its primary focus?
- NimBio was founded in January 2019. The company develops a non-invasive Inflammometer™ technology for remote care of chronic inflammatory diseases, designed to detect early signs of inflammation.
- What is NimBio's total funding raised to date?
- NimBio has raised a total of $1,370,000 USD across all its funding rounds, according to startupim data.
- Which investors participated in NimBio's Seed round in September 2019?
- In September 2019, NimBio secured Seed funding from Israel Innovation Authority and eHealth Ventures.
- What was the amount and lead investor for NimBio's Undisclosed round in November 2022?
- In November 2022, NimBio raised $870,000 USD in an Undisclosed round, with eHealth Ventures as the lead investor.
- When did NimBio complete its most recent funding round and what was the amount?
- NimBio completed a Pre-Seed round in January 2025, raising $500,000 USD. eHealth Ventures participated in this round.
- What is the current employee count for NimBio?
- NimBio currently has 5 employees.
- What recognition did NimBio receive in November 2024?
- In November 2024, NimBio was recognized as one of the thirty most promising life science and healthtech start-ups in Europe.
- What is the core technology developed by NimBio?
- NimBio develops the Inflammometer™, an AI-powered, non-invasive technology designed to passively collect real-time data for the early detection of flares in chronic inflammatory diseases.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Remote MonitoringMedical Decision Support
Technologies
SensingArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2B2C
Highlights
Verified
Tags
wearablenon-invasiveearly-detectioninflammatory-diseaseschronic-diseasedigital-healthcaredecision-supportremote-monitoringwearable